On the heels of a U.S. Senate report criticizing GlaxoSmithKline for health risks associated with its diabetes drug Avandia, a California county sued the drug maker in federal court on Friday. Santa Clara County wants the company to pay back money from all sales of Avandia in California since 1999, as well as pay restitution for medical treatment given to Avandia users who suffered heart problems. The county, which runs a public hospital, spent $2 million buying Avandia between 1999 and 2007, according to the complaint.
Font Size: 
Calif. County Sues GlaxoSmithKline Over Diabetes Drug
The Recorder
March 3, 2010
This content may be available on recorder. If the article you are looking for is older than six months, it will be available on LexisNexis.com.
